Log In
Print
BCIQ
Print
Print this Print this
 

Pulmozyme, dornase alfa

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionRecombinant deoxyribonuclease (DNase) for inhalation
Molecular Target DNA
Mechanism of ActionDegrades nucleic acid
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationCystic fibrosis (CF)
Indication DetailsImprove pulmonary function in patients with cystic fibrosis; Treat advanced cystic fibrosis (CF); Treat cystic fibrosis (CF); Treat mild to moderate cystic fibrosis (CF)
Regulatory Designation

Canada - Orphan Drug (Improve pulmonary function in patients with cystic fibrosis)

Partner

Chugai Pharmaceutical Co. Ltd.; Roche


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today